Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, Xpress minimally invasive pedicle screw, and Fortex Pedicle screw systems. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.

Xtant Medical Holdings, Inc.

Xtant Medical is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal fixation systems.

msh id	COM:XTANTMEDICAL
symbol	XTNT
name	Xtant Medical Holdings, Inc.
homepage url	https://www.xtantmedical.com
country	US
sector	Healthcare
industry	Medical - Devices
market	STOCKS
employee count	207
crunchbase url	-
linkedin url	-
founders	-

market cap	87.28M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	1.12
growth cost of revenue	1.77
growth depreciation and amortization	-1
growth ebitda	-0.87
growth ebitda ratio	0.15
growth eps	1
growth eps diluted	1
growth general and administrative expenses	0.67
growth gross profit	0.73
growth gross profit ratio	-0.21

COM:XTANTMEDICAL

Xtant Medical

Last Close

0.41

21/11 20:59

Market Cap

87.28M

Beta: -

Volume Today

243.16K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	137.3M
cost of revenue	137.3M
depreciation and amortization	-
ebitda	-10.16M
ebitda ratio	-0.08
eps	-
eps diluted	-
operating expenses	65.63M
operating income	-10.16M
operating income ratio	-0.08

accounts receivables	497K
capital expenditure	-1.46M
cash at beginning of period	20.51M
cash at end of period	5.92M
inventory	36.89M
working capital ttm	42.19M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-